Skip to Content

Lytgobi 4 mg film-coated tablet

Licence status
Authorised: 04/07/2023
Active substances
Futibatinib
Dosage Form
Film-coated tablet
Licence number
EU/1/23/1741/001-003
Licence holder
Taiho Pharma Netherlands B.V.

Licence information

ATC code
L01XE51 acalabrutinib
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
04/07/2023